Holen Sie sich die Stockscreener-App
33.95
1.02%
-0.35
Handel nachbörslich:
34.05
0.10
+0.29%
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
34.44%
74.57
|
55.47 | 46.24 | 36.56 | 34.05 |
| Operating Income/Loss |
34.44%
-74.57
|
-55.47 | -46.24 | -36.56 | -34.05 |
| Income/Loss From Continuing Operations Before Tax |
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
| Income/Loss From Continuing Operations After Tax |
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
|
Net Income/Loss
|
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.06%
112.13
|
112.07 | 0.775 | 110.91 | 110.39 |
| Diluted Average Shares |
0.06%
112.13
|
112.07 | 0.775 | 110.91 | 110.39 |
| Basic Earnings Per Share |
41.46%
-0.58
|
-0.41 | -0.32 | -0.22 | -0.20 |
| Diluted Earnings Per Share |
41.46%
-0.58
|
-0.41 | -0.32 | -0.22 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):